Bangalore, July 26 (ANI): Biotechnology major, Biocon Ltd, reported revenue of nearly 3.5 percent and a net profit of only 10 percent for the fiscal 2014-2015. Chairperson of Biocon Ltd, Kiran Mazumdar Shaw, while addressing a news conference in Bangalore said the biopharma sales were slow this quarter as compared to the previous quarters. Shaw said ongoing crisis in Middle East might have been a major reason for reduction in revenues for the biopharma and said they are looking at other global markets to compensate for the same.